Author: Lundstrom, Kenneth
Title: Alphavirus-Based Vaccines Document date: 2014_6_16
ID: 07iwwsfz_8
Snippet: Recently, VEE replicon particles generated in Vero cells were used to express the E2 glycoprotein of bovine viral diarrhea virus (BVDV) [23] . Vaccination of BVDV free calves with 1 × 10 6 IU and 1 × 10 7 IU, respectively, resulted in neutralizing antibody titers, which were able to cross-neutralize both type 1 and type 2 BVDV genotypes after booster immunizations. Vaccination with the higher dose significantly reduced the viral-based leukopeni.....
Document: Recently, VEE replicon particles generated in Vero cells were used to express the E2 glycoprotein of bovine viral diarrhea virus (BVDV) [23] . Vaccination of BVDV free calves with 1 × 10 6 IU and 1 × 10 7 IU, respectively, resulted in neutralizing antibody titers, which were able to cross-neutralize both type 1 and type 2 BVDV genotypes after booster immunizations. Vaccination with the higher dose significantly reduced the viral-based leukopenia and showed some protection from clinical disease. Similarly, VEE replicon particles were engineered to express Dengue virus E antigen in two configurations as subviral particles (prME) and soluble dimers (E85) [27] . Immunization of macaques resulted in the rapid production of neutralizing antibodies and demonstrated protection against challenges with Dengue virus. Moreover, the tetravalent E85 VEE replicon particle vaccine induced a protective response to all four Dengue virus serotypes when two immunizations were administered six weeks apart.
Search related documents:
Co phrase search for related documents- antibody titer and bovine BVDV viral diarrhea virus: 1, 2
- antibody titer and BVDV viral diarrhea virus: 1, 2
- antibody titer and clinical disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- antibody titer and Dengue virus: 1
- antibody titer and diarrhea virus: 1, 2, 3, 4, 5
- antibody titer and high dose: 1, 2, 3, 4, 5
- antibody titer and protective response: 1, 2, 3, 4, 5, 6, 7
- antibody titer and rapid production: 1
- antibody titer and Vero cell: 1, 2, 3
- antibody titer and viral diarrhea virus: 1, 2
- booster immunization and clinical disease: 1
- booster immunization and high dose: 1
- booster immunization and protective response: 1, 2
- booster immunization and Vero cell: 1
- bovine BVDV viral diarrhea virus and BVDV genotype: 1, 2
- bovine BVDV viral diarrhea virus and BVDV viral diarrhea virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- bovine BVDV viral diarrhea virus and clinical disease: 1, 2, 3, 4
- bovine BVDV viral diarrhea virus and Dengue virus: 1, 2
- bovine BVDV viral diarrhea virus and diarrhea virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
Co phrase search for related documents, hyperlinks ordered by date